M3Xtra PRO


M3Xtra, a patent-protected oral microbiome formula reduces cancer-inducing bacteria by >80% in 3 months, and lowering the risk of colon cancer.

  • M3Xtra PRO
Problem addressed

Many harmful bacteria have been proven to be involved in the development of colorectal cancer. Therefore, there is an urgent need for products that can effectively inhibit harmful bacteria and reduce the risk of colorectal cancer.

  • This innovation used big data and machine learning to identify probiotics that can effectively inhibit harmful bacteria that promote colorectal cancer.
  • This innovation selected prebiotics that can effectively promote the engraftment and growth of probiotics.
Key impact
  • Level of CRC/adenoma-related bacteria decreased o 83.3%
  • Level of good bacteria increased by 42.6%
  • Intestinal permeability decreased by 33.3 Physiological barrier restored and leaky gut prevented
  • Gold Medal at The 45th international exhibition of inventions, Geneva Switzerland
  • This product can be used to reduce the risk of colorectal cancer
  • This product can be used to treat gut dysbiosis
  • This product can promote the recovery of gut microbiota after removal of colorectal polyps
The Chinese University of Hong Kong (CUHK)

Founded in 1963, The Chinese University of Hong Kong (CUHK) is a forward-looking comprehensive research university with a global vision and a mission to combine tradition with modernity, and to bring together China and the West. CUHK teachers and students hail from all around the world. Four Nobel laureates are associated with the university, and it is the only tertiary institution in Hong Kong with recipients of the Nobel Prize, Turing Award, Fields Medal and Veblen Prize sitting as faculty in residence. CUHK graduates are connected worldwide through an extensive alumni network. CUHK undertakes a wide range of research programmes in many subject areas, and strives to provide scope for all academic staff to undertake consultancy and collaborative projects with industry.